Offer - Urjas Oil for just ₹ 1 X
Myonit Injection, a prescription drug, is manufactured in various forms such as Injection. Angina are some of its major therapeutic uses. Myonit Injection also has some secondary and off-label uses. These are listed below.
The right dosage of Myonit Injection depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Myonit Injection include Dizziness, Weakness, Drowsiness. Apart from the aforementioned side effects, Myonit Injection can also lead to other problems, which have been listed below. Normally, these side effects of Myonit Injection are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Myonit Injection's effect is Unknown during pregnancy and Unknown for lactating mothers. Warnings related to Myonit Injection's effects on the liver, heart and kidney, if any, have been listed below.
Myonit Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Anemia are examples of such conditions. The section on Myonit Injection contraindications lists all such conditions.
Additionally, Myonit Injection may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Myonit Injection is considered not safe while driving, and is not addictive.
Myonit Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Myonit Injection safe for pregnant women?
No research has been done to ascertain the safety of Myonit in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Myonit Injection safe during breastfeeding?
In the absence of any scientific study about the side effects of Myonit in breastfeeding women, information on safety of Myonit is unavailable.
What is the effect of Myonit Injection on the Kidneys?
Myonit is not harmful for kidneys.
What is the effect of Myonit Injection on the Liver?
There is no research available on the side effects of Myonit on the liver. Therefore, its impact is unknown.
What is the effect of Myonit Injection on the Heart?
Very few cases of side effects of Myonit on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Myonit Injection unless your doctor advises you to do so -
Is this Myonit Injection habit forming or addictive?
Myonit Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Myonit Injection, you should not drive or work on any heavy machine, as Myonit Injection can make you drowsy.
Is it safe?
Yes, Myonit Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Myonit Injection for mental disorders.
Interaction between Food and Myonit Injection
Taking Myonit Injection with food can create severe side effects. Discuss this with your doctor.
Interaction between Alcohol and Myonit Injection
Taking Myonit Injection and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nitrostat® (Nitroglycerin Sublingual)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540